Forendo Pharma Receives €3 Million Loan from Business Finland to Develop Novel Treatments for Endometriosis

Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, today announces that it has been granted a €3 million R&D loan from Business Finland, for the development of a novel drug for endometriosis treatment.